Inventor · disambiguated record
Gloria Gonzalez Aseguinolaza
Also filed as: GONZALEZ ASEGUINOLAZA GLORIA · GONZÁLEZ ASEGUINOLAZA GLORIA
5 granted patents·8 pending applications·39 citations·filing 2002–2021
72Inventor score
Files withFUNDACION PARA LA INVESTIG MEDICA APLICADA4VIVET THERAPEUTICS4CONSEJO SUPERIOR INVESTIGACION1FONTANELLAS ROMÁ ANTONIO1GONZALEZ ASEGUINOLAZA GLORIA1
Top patents by PatentIndex Score
13 records- 0184US8697665B2Porphobilinogen deaminase gene therapyFONTANELLAS ROMÁ ANTONIO·Filed 2009·Granted Apr 15, 2014·35 cites·5 claims
- 0279US11147887B2Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson diseaseFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2015·Granted Oct 19, 2021·4 cites·21 claims
- 0355US2022008559A1Nucleic acid constructs and gene therapy vectors for use in the treatment of wilson diseaseFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2021·Application pending·0 cites
- 0450US2022298528A1Viral particles for use in treating synucleinopathies such as parkinson's diseases by gene therapyUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 0547US2023372289A1Andrographolide derivative for use in the treatment of inflammatory diseases associated with a cytokine stormCONSEJO SUPERIOR INVESTIGACION·Filed 2021·Application pending·0 cites
- 0645US12385063B2Codon-optimized ABCB11 transgene for the treatment of progressive familial intrahepatic cholestasis type 2 (PFIC2)VIVET THERAPEUTICS·Filed 2019·Granted Aug 12, 2025·0 cites·19 claims
- 0745US2023265456A1Gene therapy vector expressing cyp27a1 for the treatment of cerebrotendinous xanthomatosisFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2021·Application pending·0 cites
- 0840US11118238B2Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson's disease and other conditionsFUNDACION PARA LA INVESTIG MEDICA APLICADA·Filed 2015·Granted Sep 14, 2021·0 cites·24 claims
- 0940US2024091382A1Minimal bile acid inducible promoters for gene therapyVIVET THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1036US2021180084A1Gene therapy vectors comprising s/mar sequencesVIVET THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1132US2012225933A1Regulated expression systemsGONZALEZ ASEGUINOLAZA GLORIA·Filed 2010·Application pending·0 cites
- 1230US2021292791A1Codon-optimized transgene for the treatment of progressive familiar intrahepatic cholestasis type 3 (pfic3)VIVET THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1327US8986711B2Vaccine to protect animals against leishmaniaLARRAGA RODRIGUEZ DE VERA VICENTE EMILIO·Filed 2002·Granted Mar 24, 2015·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Gloria Gonzalez Aseguinolaza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →